Sentinel lymph node biopsy for localised ductal carcinoma in situ?

Research output: Contribution to journalArticle

71 Citations (Scopus)

Abstract

Intraductal carcinoma of the breast (DCIS), by definition, cannot give axillary metastases. Axillary dissection is therefore not indicated. The role of the sentinel lymph node (SLN) biopsy in the management of DCIS has not yet been established. A 6-13% risk of SLN involvement is reported in Literature. The aim of the present study is to assess the role of SLN biopsy in patients with pure DCIS and attempt to identify guidelines for routine practice in managing such patients. From March 1996 to December 2003, 508 consecutive patients with pure DCIS of the breast underwent SLN biopsy at the European Institute of Oncology in Milan. Clinical and pathological data were prospectively collected. In all cases of previous surgery or stereotactic biopsy performed elsewhere all pathological slides were reviewed. Cases with microinvasion were excluded from this investigation. Lymphatic mapping was performed using a radiocolloid technique. Most of the patients underwent conservative surgery and removal of the SLN which was sent for conclusive histology. SLN metastases were detected in 9 out of 508 (1.8%) patients. In five patients only micrometastasis (

Original languageEnglish
Pages (from-to)520-522
Number of pages3
JournalBreast
Volume14
Issue number6
DOIs
Publication statusPublished - Dec 2005

Fingerprint

Sentinel Lymph Node Biopsy
Carcinoma, Intraductal, Noninfiltrating
Breast
Neoplasm Metastasis
Neoplasm Micrometastasis
Practice Guidelines
Dissection
Histology
Biopsy
Sentinel Lymph Node

Keywords

  • Breast
  • Carcinoma in situ
  • DCIS
  • Sentinel lymph node biopsy
  • Sentinel node mapping

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

@article{9be158e1ecb240ef9ac4785ce786e31e,
title = "Sentinel lymph node biopsy for localised ductal carcinoma in situ?",
abstract = "Intraductal carcinoma of the breast (DCIS), by definition, cannot give axillary metastases. Axillary dissection is therefore not indicated. The role of the sentinel lymph node (SLN) biopsy in the management of DCIS has not yet been established. A 6-13{\%} risk of SLN involvement is reported in Literature. The aim of the present study is to assess the role of SLN biopsy in patients with pure DCIS and attempt to identify guidelines for routine practice in managing such patients. From March 1996 to December 2003, 508 consecutive patients with pure DCIS of the breast underwent SLN biopsy at the European Institute of Oncology in Milan. Clinical and pathological data were prospectively collected. In all cases of previous surgery or stereotactic biopsy performed elsewhere all pathological slides were reviewed. Cases with microinvasion were excluded from this investigation. Lymphatic mapping was performed using a radiocolloid technique. Most of the patients underwent conservative surgery and removal of the SLN which was sent for conclusive histology. SLN metastases were detected in 9 out of 508 (1.8{\%}) patients. In five patients only micrometastasis (",
keywords = "Breast, Carcinoma in situ, DCIS, Sentinel lymph node biopsy, Sentinel node mapping",
author = "P. Veronesi and Mattia Intra and Vento, {A. R.} and P. Naninato and P. Caldarella and G. Paganelli and G. Viale",
year = "2005",
month = "12",
doi = "10.1016/j.breast.2005.08.007",
language = "English",
volume = "14",
pages = "520--522",
journal = "Breast",
issn = "0960-9776",
publisher = "Churchill Livingstone",
number = "6",

}

TY - JOUR

T1 - Sentinel lymph node biopsy for localised ductal carcinoma in situ?

AU - Veronesi, P.

AU - Intra, Mattia

AU - Vento, A. R.

AU - Naninato, P.

AU - Caldarella, P.

AU - Paganelli, G.

AU - Viale, G.

PY - 2005/12

Y1 - 2005/12

N2 - Intraductal carcinoma of the breast (DCIS), by definition, cannot give axillary metastases. Axillary dissection is therefore not indicated. The role of the sentinel lymph node (SLN) biopsy in the management of DCIS has not yet been established. A 6-13% risk of SLN involvement is reported in Literature. The aim of the present study is to assess the role of SLN biopsy in patients with pure DCIS and attempt to identify guidelines for routine practice in managing such patients. From March 1996 to December 2003, 508 consecutive patients with pure DCIS of the breast underwent SLN biopsy at the European Institute of Oncology in Milan. Clinical and pathological data were prospectively collected. In all cases of previous surgery or stereotactic biopsy performed elsewhere all pathological slides were reviewed. Cases with microinvasion were excluded from this investigation. Lymphatic mapping was performed using a radiocolloid technique. Most of the patients underwent conservative surgery and removal of the SLN which was sent for conclusive histology. SLN metastases were detected in 9 out of 508 (1.8%) patients. In five patients only micrometastasis (

AB - Intraductal carcinoma of the breast (DCIS), by definition, cannot give axillary metastases. Axillary dissection is therefore not indicated. The role of the sentinel lymph node (SLN) biopsy in the management of DCIS has not yet been established. A 6-13% risk of SLN involvement is reported in Literature. The aim of the present study is to assess the role of SLN biopsy in patients with pure DCIS and attempt to identify guidelines for routine practice in managing such patients. From March 1996 to December 2003, 508 consecutive patients with pure DCIS of the breast underwent SLN biopsy at the European Institute of Oncology in Milan. Clinical and pathological data were prospectively collected. In all cases of previous surgery or stereotactic biopsy performed elsewhere all pathological slides were reviewed. Cases with microinvasion were excluded from this investigation. Lymphatic mapping was performed using a radiocolloid technique. Most of the patients underwent conservative surgery and removal of the SLN which was sent for conclusive histology. SLN metastases were detected in 9 out of 508 (1.8%) patients. In five patients only micrometastasis (

KW - Breast

KW - Carcinoma in situ

KW - DCIS

KW - Sentinel lymph node biopsy

KW - Sentinel node mapping

UR - http://www.scopus.com/inward/record.url?scp=28044437506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044437506&partnerID=8YFLogxK

U2 - 10.1016/j.breast.2005.08.007

DO - 10.1016/j.breast.2005.08.007

M3 - Article

VL - 14

SP - 520

EP - 522

JO - Breast

JF - Breast

SN - 0960-9776

IS - 6

ER -